CTLA4 and neoplasm: Specifically, the CTLA-4 dual variable domain Ig (anti-CTLA-4 DVD) was designed to have the inner CTLA-4-binding domain shielded by an outer tumor-targeting anti-prostate stem cell antigen (PSCA) domain.